Vote Scores

Home / Companies / Haemonetics Corporation / 25 Jul 2024

Meeting · year to 30 June 2025507 filers reporting

Haemonetics Corporation: meeting of 25 Jul 2024

Votes reported on Form N-PX, item by item

507 Form N-PX filers reported votes at the Haemonetics Corporation meeting of 25 Jul 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

9 nominees; 97.7% of reported votes for; 13 filers withheld from or voted against at least one nominee.

3,681 vote records from 195 filers. 2 of the 195 filers that marked the item either way voted against management.

99.0% for0.0% against1.0% other1.0% against management195 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

785 vote records from 505 filers. 46 of the 492 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

88.1% for8.7% against3.2% other9.3% against management505 filers98.3% for1.5% against0.2% other1.5% against management66,084,178 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

409 vote records from 195 filers. 5 of the 195 filers that marked the item either way voted against management.

97.4% for2.1% against0.5% other2.6% against management195 filers99.9% for0.1% against0.1% other0.1% against management31,448,884 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRForForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForForFor
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForAgainst *For
Goldman SachsForForFor
WisdomTreeForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
ThriventForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustForForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonForForFor
PrincipalForForFor
Capital Group and American FundsForForFor
Pacific Life fundsForForFor
Global XForForFor
TransamericaForForFor
Federated HermesForForFor
AllianceBernsteinNo reportForNo report
Hartford FundsForForFor
DWSForForFor
PIMCOForForAgainst *
AllspringForForFor
MassMutualForForFor
Harbor FundsForForFor
VirtusForForFor
Janus HendersonNo reportForNo report
Neuberger BermanForForFor
Natixis and Loomis SaylesForForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Haemonetics Corporation meeting?

507 Form N-PX filers reported votes at the meeting of 25 Jul 2024. On say-on-pay, 46 of 492 voted against management (9.3%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Haemonetics Corporation on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Haemonetics Corporation

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Haemonetics Corporation with a meeting date within three days of 25 Jul 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.